Alector LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alector LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11311
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alector LLC (Alector) is a biotechnology company that develops therapies for immune system to cure neurodegeneration and cancer. The company discovers and develops immune modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody technology and recent discoveries in neuroimmunology and oncology to fight cancer. Alector also generates and validates antibody drugs that engage key disease altering and genetically validated neuroimmune targets. The company develops drugs through collaborations with scientists and drug developers. It operates a manufacturing facility in Milpitas, California. Alector is headquartered in South San Francisco, California, the US.

Alector LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alector LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alector LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alector LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alector LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Alector Raises USD133 Million in Series E Venture Financing 10
Alector Raises USD29.5 Million in Series D Financing 13
Alector Raises USD32 Million in Series C Financing 15
Alector Raises Funds Through Series A Financing 17
Partnerships 18
AbbVie Enters into Agreement with Alector 18
Alector Enters Into Research Agreement With Janssen Pharma 19
Alector Enters Into Research Agreement With Adimab 20
Alector LLC – Key Competitors 21
Alector LLC – Key Employees 22
Alector LLC – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Nov 16, 2018: Alector strengthens Board of Directors with appointments of David Wehner, Richard Scheller and Louis Lavigne 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Alector LLC, Pharmaceuticals & Healthcare, Key Facts 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alector LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alector LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Alector LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alector Raises USD133 Million in Series E Venture Financing 10
Alector Raises USD29.5 Million in Series D Financing 13
Alector Raises USD32 Million in Series C Financing 15
Alector Raises Funds Through Series A Financing 17
AbbVie Enters into Agreement with Alector 18
Alector Enters Into Research Agreement With Janssen Pharma 19
Alector Enters Into Research Agreement With Adimab 20
Alector LLC, Key Competitors 21
Alector LLC, Key Employees 22
Alector LLC, Other Locations 23

List of Figures
Alector LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alector LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alector LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Alector LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • MEDITE Cancer Diagnostics Inc (MDIT):企業の財務・戦略的SWOT分析
    MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Freeport-McMoRan Inc:企業のM&A・事業提携・投資動向
    Freeport-McMoRan Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Freeport-McMoRan Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Toyo Seikan Group Holdings, Ltd.:企業の戦略・SWOT・財務分析
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Malakoff Corporation Bhd (MALAKOF):電力:M&Aディール及び事業提携情報
    Summary Malakoff Corporation Bhd (Malakoff), a subsidiary of MMC Corporation Berhad, is an independent power and water producer. It generates electricity and desalinates water. The company also provides technical, simulator training, and overhaul services for CCGT, OCGT and coal-fired, multi-stage f …
  • Newcrest Mining Limited:戦略・SWOT・企業財務分析
    Newcrest Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Newcrest Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Unisem (M) Berhad (UNISEM):企業の財務・戦略的SWOT分析
    Unisem (M) Berhad (UNISEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cadence Design Systems, Inc.:企業の戦略・SWOT・財務情報
    Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • HSS Engineers Berhad (HSSEB):企業の財務・戦略的SWOT分析
    HSS Engineers Berhad (HSSEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Welltower Inc
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • China Pacific Insurance (Group) Co Ltd:企業のM&A・事業提携・投資動向
    China Pacific Insurance (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Pacific Insurance (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum) formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-relat …
  • Xbrane Biopharma AB (XBRANE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combi …
  • Oracle Energy Corp (OEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oracle Energy Corp (Oracle Energy) is an oil and gas company that operates development and redevelopment oil and natural gas projects. The company offers critical assessment and mitigation of risk in oil and gas exploration. It owns and operates oil and gas projects in Portugal's southern Lu …
  • LyondellBasell Industries NV (LYB):石油・ガス:M&Aディール及び事業提携情報
    Summary LyondellBasell Industries NV (LyondellBasell) is a chemical company. It produces and sells petrochemicals, plastics and basic chemicals. The company also refines crude oil to convert into refined products such as gasoline, diesel and jet fuel. Its major chemical products include polyolefins …
  • Phoenix Pharmahandel GmbH & Co KG:企業の戦略的SWOT分析
    Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • MTD ACPI Engineering Berhad:企業の戦略・SWOT・財務情報
    MTD ACPI Engineering Berhad - Strategy, SWOT and Corporate Finance Report Summary MTD ACPI Engineering Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Legrand SA:企業の戦略・SWOT・財務情報
    Legrand SA - Strategy, SWOT and Corporate Finance Report Summary Legrand SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Aker ASA (AKER)-石油・ガス分野:企業M&A・提携分析
    Summary Aker ASA (Aker) is an industrial investment company, which operates through in two areas, Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor A …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆